Target intelligence / Profile preview

Mitochondrial ribosome recycling factor (MRRF)

Target
MRRF
Molecular classification
Enzyme (translation factor), Other (mitochondrial translational machinery protein)
01

Overview

Mitochondrial ribosome recycling factor (MRRF) is an essential component of the mitochondrial translational machinery. It participates in the final step of mitochondrial protein synthesis, mediating the recycling of mitoribosomes—specifically, the dissociation of ribosomes from mRNA at the end of translation. MRRF partners with mitochondrial elongation factor G2 (EF-G2mt) in a process that ensures the proper separation of ribosomal subunits for subsequent rounds of translation, maintaining the integrity of mitochondrial function. MRRF is required for cell viability; depletion leads to aggregation of mitoribosomes, severe mitochondrial structural defects, increased oxidative stress, loss of respiratory complexes, and cell death. The mammalian MRRF is encoded in the nuclear genome and targeted to mitochondria, with unique structural features distinct from both bacterial and chloroplast RRFs. Though not exploited directly by approved drugs, its bacterial homolog is a validated target for antibiotic development.

Other names
MRRFRRFmtRRFMTRRFMRFFRibosome-recycling factor, mitochondrialRibosome-releasing factor, mitochondrialRRFmtRibosome release factor
02

Mechanism of action

Inhibition of ribosome recycling and protein synthesis (proposed for antibiotics acting on bacterial RRF)

03

Biological functions

Ribosome recycling (disassembly of ribosomal complex post-translation)Mitochondrial protein synthesisRegulation of oxidative phosphorylationMaintenance of mitochondrial genome stability (in yeast and human cell models)
04

Disease associations

Mitochondrial disease (e.g., genetic diseases linked to mitochondrial dysfunction)Cellular viability (lethal when depleted)Potential target in bacterial infection (because bacterial RRF is essential for bacterial survival)Other (respiratory incompetence in yeast models)
05

Safety considerations

Loss or deficiency of MRRF is lethal to cells due to impairment of mitochondrial functionTherapeutic targeting could risk mitochondrial dysfunction and cytotoxicity in humans if specificity for bacteria is not ensured
06

Interacting drugs

No interacting drugs are currently known for the human mitochondrial form, but the bacterial homolog is a proposed target for new antibacterial drugs

1 more in the full profile.

07

Biomarkers

None established for MRRF in patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Mitochondrial ribosome recycling factor (MRRF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial ribosome recycling factor (MRRF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call